Searched for
MYLAN PHARMACEUTICALS PVT LTD
Pfizer board approves marketing, supply pact with Mylan for two brandsPfizer Ltd's board has approved a five-year marketing and supply agreement with Mylan Pharmaceuticals for the brands Ativan and Pacitane, t...- Will PLI help Indian pharma gain market share at cost of MNCs?Indian pharmaceutical companies are becoming more aggressive and increasing their market share and capex. Companies such as Divis, Dr Reddy...
- Pfizer Q2 results: Net profit up 9% to Rs 143 croreRevenue from operations stood at Rs 636.26 crore for the quarter under consideration, as against Rs 595.41 crore a year ago, it added.
- Stocks in the news: YES Bank, Biocon, IndiGo, L&T, Canara Bank and AirtelBiocon said a US court has invalidated a Sanofi patent on the insulin glargine device.
- Stocks in the news: YES Bank, HDIL, Manpasand Beverages, Adani Green and NMDCThe company has filed a police complaint regarding hostile takeover.
- And you thought pharma pain will go away anytime soon? Read thisIndia was already the world’s largest exporter of generic drugs, with $16.4 bn sold abroad last year.
- Billionaire Dilip Shanghvi offers mea culpa after Sun Pharma lossSun was tipped into a loss this quarter after it agreed to pay plaintiffs including Canadian rival Apotex to settle a lawsuit over sleep-di...
- CCI orders detailed probe against pharma major RocheAccording to the CIC, Roche Group is dominant in the relevant market and can operate independently of the market forces.
- With Sun Pharma set for its worst decline, Dilip Shanghvi faces his greatest testHis relentless drive has helped make Sun India’s biggest drugmaker and best performing stock over 20 years - and Shanghvi the country’s 2nd...
- Mylan launches generic Hepatitis C drug in IndiaDrug firm Mylan NV has launched generic Harvoni tablets, used to treat Hepatitis C, under the brand name 'MyHep LVIR' in India.
- Govt approves 11 FDI proposals valued at Rs 1,076 cr; refers Aurobindo, Glenmark proposals to CCEAThe Finance Ministry today referred FDI proposals worth Rs 4,187 crore in pharma firms - Glenmark and Aurobindo - to the Cabinet Committee ...
- Mylan launches breast cancer drug in IndiaDrug major Mylan Inc today said it has launched breast cancer drug Hertraz Herceptin in India.
- USFDA warning letter to Agila not to affect acquisition: MylanMylan said the USFDA warning letter to Agila Specialties over violation of manufacturing norms in one of its plants will not affect the Rs ...
- Govt clears Mylan's Rs 5,168-cr deal to acquire Agila SpecialtiesThe decision was taken at a meeting of the Cabinet Committee of Economic Affairs held, Information and Broadcasting Minister Manish Tiwari ...
- FIPB clears US pharma major Mylan's Rs 5,168 crore FDI proposalUS-based Mylan Inc's Rs 5,168 crore proposal to acquire Agila Specialties Pvt Ltd -- a subsidiary of pharma firm Strides Arcolab -- was cle...
- FIPB to take up 32 foreign investment proposals on TuesdayFDI in India increased by about 16 per cent year-on-year to $ 1.44 billion in June, which is the lowest figure during the calender year.
- CCI gives green signal to Strides Arcolab-Mylan dealCCI has approved the acquisition of a Strides Arcolab subsidiary by Mylan, saying the deal will not have an adverse impact on competition i...
Load More
